Nasdaq · Healthcare
NRC HEALTH (NRC)
As-reported financials and recent SEC filings for NRC HEALTH, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$137.4M
Net income
$11.6M
Net margin
8.4%
Diluted EPS
$50.00
ROE
82.9%
P/E (TTM)
—
Market cap
—
Debt / equity
5.4×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $137.4M | $143.1M | $148.6M | $151.6M | $148.0M |
| Gross profit | — | — | — | — | — |
| Operating income | $22.6M | $35.2M | $40.0M | $46.5M | $50.3M |
| Net income | $11.6M | $24.8M | $31.0M | $31.8M | $37.5M |
| Diluted EPS | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-29
View on EDGAR →42026-06-25
View on EDGAR →42026-06-25
View on EDGAR →42026-06-25
View on EDGAR →42026-06-25
View on EDGAR →42026-06-25
View on EDGAR →SCHEDULE 13D/A2026-06-12
View on EDGAR →424B72026-05-13
View on EDGAR →Largest Healthcare peers
Go deeper on NRC
Search NRC HEALTH’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.